IPCA LABORATORIES LTD.
BSE: 524494
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 1.8K-1.7% | 1.8K-4.4% | 1.9K+10.5% | 1.7K+6.6% | 1.6K-1.5% | 1.7K-8.2% | 1.8K |
| Other Income | 29.88+67.7% | 17.82-18.7% | 21.92-12.4% | 25.02+16.4% | 21.49+23.4% | 17.41+2.4% | 17.00 |
| Total Income | 1.8K-1.0% | 1.9K-4.6% | 2.0K+10.2% | 1.8K+6.7% | 1.7K-1.2% | 1.7K-8.1% | 1.8K |
| EXPENSES | |||||||
| Expenditure | 1.5K+1.3% | 1.4K-6.4% | 1.5K+9.1% | 1.4K+4.0% | 1.4K+2.8% | 1.3K-11.0% | 1.5K |
| Tax | 87.56-23.0% | 113.77+9.8% | 103.57+9.4% | 94.71+15.2% | 82.20-6.5% | 87.96-7.5% | 95.09 |
| PROFIT | |||||||
| PBT | 349.85-16.1% | 417.22+2.2% | 408.31+14.5% | 356.75+1980.2% | 17.15-95.2% | 355.52+4.8% | 339.21 |
| Net Profit | 262.29-13.6% | 303.45-0.4% | 304.74+16.3% | 262.04+502.8% | -65.05-124.3% | 267.56+9.6% | 244.12 |
| KEY METRICS | |||||||
| OPM % | 22.09%-3.79pp | 25.88%+1.81pp | 24.07%+0.78pp | 23.29%+18.59pp | 4.70%-11.25pp | 15.95%+2.57pp | 13.38% |
| NPM % | 14.22%-2.07pp | 16.29%+0.68pp | 15.61%+0.82pp | 14.79%+18.71pp | -3.92%-19.85pp | 15.93%+2.58pp | 13.35% |
| EPS | 10.34-13.5% | 11.96-0.4% | 12.01+16.3% | 10.33+303.5% | 2.56-75.7% | 10.55+9.7% | 9.62 |
Corporate Events
Board MeetingIPCALAB
202414Nov
Board Meeting
consider and approve Standalone and Consolidated Financial R…
BSE Filing ↗ Board MeetingIPCALAB
202430Sep
Board Meeting
Integration and consolidation of the generics formulations b…
BSE Filing ↗ Board MeetingIPCALAB
202429May
Board Meeting
Consideration and approval of Standalone and Consolidated Au…
BSE Filing ↗ Board MeetingIPCALAB
202414Feb
Board Meeting
Consider and approve Unaudited Standalone and Consolidated F…
BSE Filing ↗ Board MeetingIPCALAB
202310Nov
Board Meeting
Consideration and approval of Standalone and Consolidated Un…
BSE Filing ↗